Biotech Firm Nears Revival of Extinct Tasmanian Tiger

Colossal Biosciences has almost completed the genome of the Tasmanian tiger, moving closer to potentially reintroducing the species to its native habitat.

The Tasmanian tiger, extinct since 1936, may soon be revived thanks to breakthroughs in genetic reconstruction by Colossal Biosciences.
Scientists have restored 99.9% of the thylacine genome, with only 45 gaps remaining, using DNA from well-preserved specimens.
Colossal Biosciences aims to implant the complete genome into a Dasyurid egg to produce the first new Tasmanian tiger joeys.
The project is part of broader efforts by the company to de-extinct species, including the woolly mammoth and potentially the dodo.
The reintroduction of the Tasmanian tiger could help restore ecological balance in its former habitat in Tasmania.